Skip to main content
SpringerLink
Log in

Ibrutinib-related risk of serious infections and invasive fungal infections

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tham K, et al. Infectious complications among patients receiving ibrutinib for the treatment of hematological malignancies. American Journal of Health-System Pharmacy : 7 Sep 2023. Available from: URL: http://doi.org/10.1093/ajhp/zxad210

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ibrutinib-related risk of serious infections and invasive fungal infections. Reactions Weekly 1974, 12 (2023). https://doi.org/10.1007/s40278-023-46023-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-46023-2

Search

Navigation